Drug Profile
EXT 400
Alternative Names: EXT-400Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Extend Biosciences
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Diabetes-mellitus in USA (SC, Injection)
- 19 Jul 2016 Early research in Diabetes mellitus in USA (SC)